Wednesday, July 2, 2025 7/2/2025

Vagus nerve stimulation modulates synaptic plasticity in the rat prefrontal cortex during the extinction of drug-seeking

Award Number: R01DA055008
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2022
PERIOD OF PERFORMANCE END DATE: 01/31/2027

Group Awards By:

View Award Description

Vagus nerve stimulation modulates synaptic plasticity in the rat prefrontal cortex during the extinction of drug-seeking - Drug use causes the formation of strong cue/reward associations which persist long after cessation of drug-taking and contribute to the long-term risk of relapse. Breaking these associations is an important goal in the treatment of substance use disorders. Extinction is a form of learning that inhibits behavioral responses to a learned stimulus. Modulating extinction processes and consolidating the newly-formed memories has clinical potential to reshape maladaptive behavior and to prevent relapse. We have recently shown that vagus nerve stimulation (VNS) facilitates extinction learning and reduces cue-induced reinstatement of drug-seeking in cocaine self-administering rats. These changes correlate with altered activity in a network that centers on the infralimbic (IL) cortex. Our preliminary data also show that drug-taking and reinstatement reduce AMPA-receptor currents at layer 5 IL pyramidal neurons, and that VNS reverses these changes. Systemic blockade of TrkB receptors for the brain-derived neurotrophic factor (BDNF) during extinction abolishes VNS’ effects on cue-induced reinstatement and on glutamatergic transmission in the IL. We hypothesize that extinction training reverses drug-induced changes in synaptic AMPARs in the IL. Pairing extinction with VNS leads to (additional) BDNF release which consolidates these changes and reduces reinstatement. In this application we will use a combination of behavioral, electrophysiological, and celltype-specific morphological analyses to 1) further investigate the time- and circuit-specific dysfunctional neuroadaptations in the IL that contribute to drug-seeking and relapse, and 2) to determine the mechanisms through which VNS consolidates extinction memory to reduce relapse. Experiments in Aim 1 will use patch-clamp electrophysiology and optogenetic stimulation of afferents from the basolateral amygdala (BLA) to the IL to determine how these inputs are altered by drug-seeking, extinction, and VNS. We will perform voltage-clamp recordings from 2 types of IL projection neurons (to the BLA and Nucleus accumbens shell) and determine VNS-induced changes in postsynaptic glutamate receptor function and presynaptic release during extinction and reinstatement. These experiments will be supported with morphological analyses in the same type of IL projection neurons to determine VNS-induced changes specifically in cells that were activated by reinstatement (labeled by the activity marker pCREB) to test our hypothesis that VNS preferentially modulates networks relevant in behaviors paired with VNS. In Aim 2 we will determine whether the VNS-induced consolidation of extinction depends on endogenous BDNF levels in the IL or its inputs. To this end we will use CRISPR/Cas9 to knock down BDNF produced either from cells within the IL or from cells in the hippocampus that project to the IL, respectively, in order to determine how VNS-evoked BDNF modulates extinction and reinstatement. Experiments in Aim 3 will determine the importance of VNS-induced BDNF release to changes in synaptic plasticity and morphology in cells that regulate relapse. We will also record in-vivo local field potentials in the BLA and the NACshell to determine how BDNF knockdown affects VNS’ ability to modulate synaptic plasticity in the outputs of the IL. Taken together, our studies will provide important novel information about cocaine- and extinction-induced synaptic changes in the IL, and they will identify glutamatergic and BDNF-dependent mechanisms through which VNS can reduce relapse.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $410,663 )
2025	2025	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Drug Use and Addiction Research Programs	000	4	3/3/2025	NON-COMPETING CONTINUATION	$369,597
2025	2025	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Drug Use and Addiction Research Programs	001	4	4/9/2025	NON-COMPETING CONTINUATION	$41,066
														Subtotal = $410,663

Issue Date FY: 2024 ( Subtotal = $409,327 )
2024	2024	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Drug Use and Addiction Research Programs	000	3	1/17/2024	NON-COMPETING CONTINUATION	$368,396
2024	2024	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Drug Use and Addiction Research Programs	001	3	4/24/2024	NON-COMPETING CONTINUATION	$40,931
														Subtotal = $409,327

Issue Date FY: 2023 ( Subtotal = $378,787 )
2023	2023	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Drug Use and Addiction Research Programs	000	2	1/16/2023	NON-COMPETING CONTINUATION	$378,787
														Subtotal = $378,787

Issue Date FY: 2022 ( Subtotal = $355,335 )
2022	2022	UNIVERSITY OF TEXAS AT DALLAS	800 W CAMPBELL RD	RICHARDSON	TX	75080	DALLAS	USA	Drug Use and Addiction Research Programs	000	1	3/18/2022	NEW	$355,335
														Subtotal = $355,335

Grand Total All Awards = $1,554,112

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Vagus nerve stimulation modulates synaptic plasticity in the rat prefrontal cortex during the extinction of drug-seeking

Award Number: R01DA055008

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2022

PERIOD OF PERFORMANCE END DATE: 01/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer